Research programme: biodefence vaccines - ViRexx

Drug Profile

Research programme: biodefence vaccines - ViRexx

Alternative Names: Biodefense vaccines - ViRexx; WEEV vaccines - ViRexx; Western equine encephalitis vaccines - ViRexx

Latest Information Update: 02 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ViRexx Medical Corp
  • Developer Defence Research and Development Canada; Paladin Labs
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Western equine encephalitis virus infections

Most Recent Events

  • 23 Dec 2008 ViRexx Medical Corp has been acquired and merged into Paladin Labs
  • 25 May 2008 Preclinical development is ongoing in Western equine encephalitis virus infections in Canada
  • 13 Apr 2006 Preclinical trials in Viral infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top